| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |